SHED-CM: The Safety and Efficacy of Conditioned Media from Human Exfoliated Deciduous Teeth Stem Cells in Amyotrophic Lateral Sclerosis (ALS) Treatment - A Retrospective Cohort Analysis_hitonowamedical

This is the raw data from the study below.SHED-CM: The Safety and Efficacy of Conditioned Media from Human Exfoliated Deciduous Teeth Stem Cells in Amyotrophic Lateral Sclerosis (ALS) Treatment - A Retrospective Cohort AnalysisThis was a retrospective cohort study including patients diagnosed with ALS who visited our hospital between January 1, 2022, and November 30, 2023. We enrolled pa-tients with ALS who received SHED-CM within this period, had a score of 12 or higher on the ALS Functional Rating Scale-Revised (ALSFRS-R), and did not undergo trache-ostomy. All administered data were evaluated for safety. Several patients experienced difficulties presenting to the hospital due to the progression of their ALS; therefore, we evaluated the efficacy of the drug from the first to the 12th dose, which were adminis-tered consecutively, and for which all patients presented to the hospital.